Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Encora X1™. “We started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results